Ceftaroline Fosamil Versus Standard of Care for Community Acquired Bacterial Pneumonia: Clinical Outcomes Among Hospitalized Adults at a Single United States Hospital

Trial Profile

Ceftaroline Fosamil Versus Standard of Care for Community Acquired Bacterial Pneumonia: Clinical Outcomes Among Hospitalized Adults at a Single United States Hospital

Completed
Phase of Trial: Phase III

Latest Information Update: 21 Mar 2015

At a glance

  • Drugs Ceftaroline fosamil (Primary) ; Azithromycin; Cephalosporins; Clarithromycin
  • Indications Bacterial infections; Pneumonia
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top